This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2007-2011.
Company Filing History:
Years Active: 2007-2011
Title: Will Spooren: Innovator in Pharmaceutical Chemistry
Introduction
Will Spooren is a notable inventor based in Franken, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for various medical applications. With a total of 3 patents to his name, Spooren's work has the potential to impact the treatment of several neurological and psychological disorders.
Latest Patents
One of Spooren's latest patents involves the creation of 4-aryl-pyridine-2-carboxyamide derivatives. This invention relates to novel pyridine-2-carboxyamide derivatives that are useful as metabotropic glutamate receptor antagonists. The specific formula and components are detailed in the patent specification. Another significant patent focuses on compounds that have been found to be active on the GABA receptor. These compounds are promising for the treatment of anxiety, depression, epilepsy, schizophrenia, cognitive disorders, spasticity, and various other conditions.
Career Highlights
Throughout his career, Will Spooren has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Some of Spooren's notable coworkers include Eric Prinssen and Raffaello Masciadri. Their collaborative efforts have contributed to the advancement of innovative solutions in the pharmaceutical sector.
Conclusion
Will Spooren's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.